73.72
Metsera Inc Borsa (MTSR) Ultime notizie
Novo Nordisk Outbids Pfizer In $10 Billion Metsera Takeover Battle - Finimize
Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera - Barron's
Palantir, Hertz, Metsera, Uber, DraftKings: Stocks Making The Biggest Moves Today - Stocktwits
Teneo Refs Bidding War for Metsera - O'Dwyer's PR
Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle - MarketScreener
Pfizer Metsera Lawsuit - Buffalo News
M&A News: Novo Nordisk Stock (NVO) Slides after Increasing Its Metsera Offer to $10B - TipRanks
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera By Reuters - Investing.com
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo - WTAQ
Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer - WFMZ.com
Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera - Proactive financial news
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Reuters
Metsera’s Shares Spike Amid Acquisition Proposals from Novo Nordisk and Pfizer - StocksToTrade
Takeover Saga for Obesity Drugmaker Metsera Heats Up - Bloomberg
Metsera rises after Novo Nordisk and Pfizer sweeten bids - TradingView
Novo Nordisk (NVO) Raises Bid to Acquire Metsera, Outbidding Pfi - GuruFocus
Delaware court won't rule on Pfizer/Novo battle for Metsera today - Seeking Alpha
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo By Reuters - Investing.com
Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion - Investor's Business Daily
Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera - BioSpace
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - Yahoo Finance
Metsera Considers Novo Nordisk’s Superior Acquisition Proposal - TipRanks
Novo Nordisk’s (NVO) $9B Metsera Bid Sparks Showdown with Archrival Pfizer (PFE) - TipRanks
Metsera receives amended ‘superior’ proposal from Novo Nordisk - TipRanks
Metsera saga continues, with upped bids from Novo and Pfizer - The Pharma Letter
Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup - The Wall Street Journal
Pfizer & Novo boost Metsera bids, Hertz stock skyrockets - Yahoo Finance
Metsera Inc Declares Novo Nordisk Proposal Superior - TradingView
Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger - MarketScreener
Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga - Bloomberg.com
Novo Nordisk Hikes Metsera Bid to up to $10B in Competition With Rival Pfizer - U.S. News & World Report
Novo Nordisk (NVO) Extends Enhanced Acquisition Offer for Metser - GuruFocus
/C O R R E C T I O N -- Metsera, Inc./ - Placera.se
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - Reuters
NVO's Acquisition Offer Values Metsera at $10B - GuruFocus
Novo, Pfizer's bidding war heats up with supercharged offers for Metsera - Fierce Biotech
Pfizer, Novo Nordisk improve offers for Metsera as bidding war escalates - Capital Brief
Metsera, Inc. Stock Soars Amid Acquisition Drama - TipRanks
Metsera Receives Amended Proposal from Novo Nordisk - citybiz
Novo Nordisk (NVO) Offers Enhanced Proposal to Metsera - GuruFocus
Novo Nordisk and Pfizer sweeten bids for Metsera - Axios
Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid - BioSpace
Metsera stock soars as Novo Nordisk, Pfizer sweeten bids in takeover battle - Investing.com
Novo Nordisk Sweetens Offer for Metsera - The Wall Street Journal
Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg
Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates - statnews.com
Novo Nordisk submits updated proposal to acquire Metsera - MarketScreener
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters - Stocktwits
Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer - CNBC
Novo Nordisk submits updated proposal to acquire Metsera, Inc. - The Manila Times
Both Novo Nordisk and Pfizer have adjusted their bids for Metsera. - MarketScreener
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up By Reuters - Investing.com
Novo Nordisk values Metsera at $86.20 per share in takeover bid - Investing.com
Novo Nordisk sweetens bid for Metsera with an offer of up to $10 billion - Yahoo! Finance UK
Metsera Gets Higher Offers From Pfizer, Novo in Takeover Saga - Bloomberg
Pfizer Q3 Results Signal Shift From Covid Windfall to Obesity-Driven Growth Path - Investing.com
Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies - Financial Times
Legal battle erupts between Pfizer and Novo Nordisk for Metsera - Benefits and Pensions Monitor
With new bids in hand, Metsera declares Novo's $10B offer better than Pfizer's - FirstWord Pharma
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):